Sacha Loiseau, Ph.D, President, CEO and Founder of Mauna Kea Technologies, discusses how his firm delivers a higher level of clinical efficiency, accuracy and cost-effectiveness while paving the way for new investigative horizons.

Mauna Kea Technologies flagship product, Cellvizio®, is the world's smallest and most flexible microscope and the first system designed to provide live, real-time images of internal human tissues at the cellular level during endoscopic procedures of the pulmonary and gastrointestinal tracts. This advanced imaging technique, essentially an “optical biopsy,” helps physicians more effectively assess tissues of interest and differentiate normal versus abnormal tissues that may be indicative of cancer. This new imaging modality provides physicians the potential to enable earlier diagnosis of cancerous tissues and to reduce the number of unnecessarily invasive and expensive biopsies.